Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women.

Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Abstract Text:

Lalita Khaodhiar,Hope A Ricciotti,Linglin Li,Weijun Pan,Mary Schickel,Jinrong Zhou,George L Blackburn,

OBJECTIVE: The aim of this study was to determine the effect of DRIs on hot flash symptoms in menopausal women.DESIGN: This was a randomized, double-blind, placebo-controlled trial of menopausal women, aged 38 to 60 years, who experienced 4 to 14 hot flashes per day. After a 1-week run-in period, a total of 190 menopausal women were randomized to receive a placebo or 40 or 60 mg/day of a DRI for 12 weeks. The primary outcome was the mean changes from baseline to week 12 in the frequency of hot flashes recorded in the participant diary. The secondary outcomes included changes in quality of life and hormonal profiles.RESULTS: A total of 147 women (77%) completed the study. It was found that 40 and 60 mg of DRI improved hot flash frequency and severity equally. At 8 weeks hot flash frequency was reduced by 43% in the 40-mg DRI group and by 41% in the 60-mg DRI group, compared with 32% in the placebo group (P = not significant vs placebo). The corresponding numbers for 12 weeks were 52%, 51%, and 39%, respectively (P = 0.07 and 0.09 vs placebo). When comparing the two treatment groups with the placebo group, there were significant reductions in mean daily hot flash frequency. The supplement (either 40 or 60 mg) reduced hot flash frequency by 43% at 8 weeks (P = 0.1) and 52% at 12 weeks (P = 0.048) but did not cause any significant changes in endogenous sex hormones or thyroid hormones. Menopausal quality of life improved in all three groups, although there were no statistically significant differences between groups.CONCLUSIONS: DRI supplementation may be an effective and acceptable alternative to hormone treatment for menopausal hot flashes.

Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Publishing Authors By Initials

L Khaodhiar,HA Ricciotti,L Li,W Pan,M Schickel,J Zhou,GL Blackburn,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Menopause (New York, N.Y.)

VOLUME: 15

Page Numbers: 125-32

Journal Abbreviation:

ISSN: 1072-3714

DAY: 6

MONTH: 02

YEAR: 2008

Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9433353

Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women.

AFFILIATION: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Menopause

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women Related Publications

• A multinuclear copper(I) cluster forms the dimerization interface in copper-loaded human copper chaperone for superoxide dismutase.
• A newly recognised strain of Staphylococcus aureus associated with epidemics in six hospitals.
• A preschool program at East York Health Unit.
• A short history of dentistry in ancient times.
• A3 adenosine receptor signaling contributes to airway mucin secretion after allergen challenge.
• Breast-feeding Internet Resources.
• Cardiovascular survey methods.
• Coarctation of the aorta in a man, aged 63 years.
• Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women.
• Diet and breast cancer recurrence.
• Disequilibrium due to a vitamin B6 megadose supplement.
• Expression and suppression of human telomerase RNA.
• FLUOROMETHOLONE (NSC-33001) AS A PALLIATIVE IN ADVANCED GASTROINTESTINAL CARCINOMA.
• Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice.
• Human cancer cells harbor T-stumps, a distinct class of extremely short telomeres.
• Insidious onset neck pain - a symptom not to be dismissed.
• Large scale production of the copper enzyme peptidylglycine monooxygenase using an automated bioreactor.
• Ligand dependent release of activated neutrophil collagenase--a role for surface bound IgG in the degradation of articular collagens.
• MONOSEMICARBAZONE OF ADRENOCHROME (ADRENOXYL) AND CATARACT SURGERY EFFECT ON CAPILLARY RESISTANCE AND INCIDENCE OF HYPHAEMA.
• One-solvent polymorph screen of carbamazepine.
• Proteins synthesized in medial hypothalamus and transported to midbrain in estrogen-treated female rats.
• Selected internet resources relating to trauma and violence in women and infants.
• Spatial turnover in the global avifauna.
• The Telotype Defines the Telomere State in Saccharomyces cerevisiae and Is Inherited as a Dominant Non-Mendelian Characteristic in Cells Lacking Telomerase.
• The low-fat imperative.
• The role of lead in the reduction of the erythrocyte sedimentation rate by hyaluronidase.
• Thymus organogenesis and development of the thymic stroma.
• Use of 2alpha-methyldihydrotestosterone propionate in treatment of advanced cancer of the breast: a group report.
• Using aliens to explore how our planet works.
• VINCRISTINE (NSC-67574) THERAPY OF ADULT PATIENTS WITH SOLID TUMORS.